Neurocrine Biosciences Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $3.0M | $-53.7M | $-51.0M |
| FY2010 | $33.5M | $-13.7M | $-8.0M |
| FY2011 | $77.4M | $33.9M | $37.6M |
| FY2012 | $53.1M | $1.4M | $5.0M |
| FY2013 | $2.9M | $-49.7M | $-46.1M |
| FY2014 | $0 | $-64.4M | $-60.5M |
| FY2015 | $19.8M | $-94.2M | $-88.9M |
| FY2016 | $15.0M | $-147.4M | $-141.1M |
| FY2017 | $161.6M | $-131.4M | $-142.5M |
| FY2018 | $451.2M | $36.8M | $21.1M |
| FY2019 | $788.1M | $72.3M | $37.0M |
| FY2020 | $1.05B | $163.0M | $407.3M |
| FY2021 | $1.13B | $102.5M | $89.6M |
| FY2022 | $1.49B | $249.0M | $154.5M |
| FY2023 | $1.89B | $250.9M | $249.7M |
| FY2024 | $2.36B | $570.5M | $341.3M |
| FY2025 | $2.86B | $619.1M | $478.6M |